Prognostic value of metabolic tumor volume on PET/CT in primary gastrointestinal diffuse large B cell lymphoma

Cancer Science

Volumn 103, Issue 3, 2012, Pages 477-482

  Song, Moo Kon ^a   Chung, Joo Seop ^a   Shin, Ho Jin ^a   Moon, Joon Ho ^b   Lee, Jeong Ok ^c   Lee, Ho Sup ^d   Lee, Sang Min ^e   Lee, Gyeong Won ^f   Lee, Su Ee ^g   Kim, Seong Jang ^a  

^a Pusan National University Hospital   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Kosin University   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Gyeongsang National University   (South Korea)

^g Dong A Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METABOLIC TUMOR VOLUME; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIMARY GASTROINTESTINAL DIFFUSE LARGE B CELL LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; TUMOR VOLUME; ABDOMINAL SURGERY; AREA UNDER THE CURVE; DISEASE FREE SURVIVAL; GASTROINTESTINAL TUMOR; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; ROC CURVE; YOUNG ADULT;

EID: 84859741903     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02164.x     Document Type: Article

References (23)

1. d'Amore F, Brincker H, Grønbaek K et al. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 1994; 12: 1673-84.
2. Koch P, del Valle F, Berdel WE et al. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19: 3861-73.
3. Papaxoinis G, Papageorgiou S, Rontogianni D et al. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma 2006; 47: 2140-6.
4. Tanaka T, Shimada K, Yamamoto K et al. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan. Ann Hematol 2011; 10.1007/s00277-011-1306-0 [Epub ahead of print].
5. Wöhrer S, Püspök A, Drach J et al. Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann Oncol 2004; 15: 1086-90.
6. Stumpe KD, Urbinelli M, Steinert HC et al. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Eur J Nucl Med 1998; 25: 721-8.
7. Spaepen K, Stroobants S, Dupont P et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods. J Clin Oncol 2001; 19: 414-9.
8. Juweid ME, Stroobants S, Hoekstra OS et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-8.
9. max) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol 2011; 93: 502-28.
10. Yi JH, Kim SJ, Choi JY et al. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma. Hematol Oncol 2010; 28: 57-61.
11. Freudenberg LS, Antoch G, Schütt P et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2004; 31: 325-9.
12. Grow A, Quon A, Graves E et al. Metabolic tumor volume as an independent prognostic factor in lymphoma (Abstract). J Clin Oncol 2005; 23(Suppl. 1): 6694.
13. Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961; 49: 80-9.
14. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42.
15. Cheson BD, Pfistner B, Juweid ME et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-86.
16. Lartizien C, Kinahan PE, Swensson R, Comtat C, Lin M, Villemagne V, Trébossen R. Evaluating image reconstruction methods for tumor detection in 3-dimensional whole-body PET oncology imaging. J Nucl Med 2003; 44: 276-90.
17. Pandey M, Wadhwa MK, Patel HP, Kothari KC, Shah M, Patel DD. Malignant lymphoma of the gastrointestinal tract. Eur J Surg Oncol 1999; 25: 164-7.
18. Ruskoné-Fourmestraux A, Aegerter P, Delmer A, Brousse N, Galian A, Rambaud JC. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology 1993; 105: 1662-71.
19. Ferreri AJ, Montalbán C. Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol 2007; 63: 65-71.
20. Bonnet C, Fillet G, Mounier N et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2007; 25: 787-92.
21. Lee J, Kim WS, Kim K et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res 2007; 31: 359-64.
22. Daum S, Ullrich R, Heise W et al. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal Non-Hodgkin's Lymphoma. J Clin Oncol 2003; 21: 2740-6.
23. Kim SJ, Kang HJ, Kim JS et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood 2011; 117: 1958-65.